Title
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology
Authoring Organizations
Publication Month/Year
May 22, 2024
Last Updated Month/Year
May 22, 2024
Document Type
Other
Country of Publication
US
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Home health, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, community pharmacist, health systems pharmacist, pharmacy technician, physician, physician assistant
Scope
Treatment, Management, Prevention
Diseases/Conditions (MeSH)
D002173 - Cancer Care Facilities, D000903 - Antibiotics, Antineoplastic, D000964 - Antimetabolites, Antineoplastic, D000970 - Antineoplastic Agents, D018906 - Antineoplastic Agents, Alkylating, D000074322 - Antineoplastic Agents, Immunological, D000972 - Antineoplastic Agents, Phytogenic, D000971 - Antineoplastic Combined Chemotherapy Protocols, D024221 - Antineoplastic Protocols
Keywords
antineoplastic agents, standards, antineoplastic therapy
Source Citation
Siegel RD, LeFebvre KB, Temin S, et al. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. JCO Oncol Pract. 2024 May 22. doi: 10.1200/OP.24.00216.